Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Misr University for Science and Technology | OTHER |
Not provided
Not provided
Not provided
The study will compare the clinical and radio-graphic performance of newly introduced non-staining bio-active bio-ceramic (Neo MTA 2) versus White MTA used as coronal plug material in revascularization of non-vital immature permanent anterior teeth.Visual examination, palpation, A measuring scale in digital radio-graph software (DIGORA for Windows software) will be used for evaluation.
Mineral trioxide aggregate (MTA) has been widely used in revascularization procedures for coronal sealing in more than 85% of studies for privilege of bio compatibility, good sealing properties, and marginal adaptation. However, its poor handling characteristics and potential coronal discoloration effects are the major disadvantages of using mineral trioxide aggregate.
Although white MTA (WMTA) has been developed to overcome the tooth discoloration caused by the application of grey MTA, several in vivo and in vitro studies have also reported tooth discoloration after using WMTA.
To overcome the problems associated with WMTA, a new modification was introduced to the market called NeoMTA 2 as a new hope to overcome the discoloration problem. NeoMTA 2 provides easier handling, shorter setting time, and better color. The lack of post-operative discoloration problems was mainly due to the absence of Bismuth oxide in NeoMTA.
up to date, no clinical trials have reported the clinical and radio-graphic outcomes after revascularization of non-vital immature permanent anterior teeth using Neo MTA 2. Thus, the present study aims to evaluate and compare clinically and radio-graphically the effect of using two different coronal plug materials (Neo MTA 2 versus White mineral trioxide aggregate) in revascularization of non-vital immature permanent anterior teeth.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I | Experimental | NeoMTA 2 Manipulation and mixing will be done according to manufacturer instructions:
|
|
| Group II | Active Comparator | White mineral trioxide aggregate
The mix will be placed over the collagen matrix 2mm beneath the clinical cement-enamel junction. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NeoMTA2 | Drug | Bio-active bio-ceramic mineral trioxide aggregate |
|
| Measure | Description | Time Frame |
|---|---|---|
| Discoloration | Using shade guide (VITA classical) | 1 year |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| swelling | Clinical examination (Visual examination and palpation of the labial vestibule and the palatal area related to every affected tooth) | 1 year |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ola Mourad, Msc | Contact | 01062952921 | ola.abdelkader@dentistry.cu.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| Youssef | Cairo University | Study Director |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Triple(Patients, radio-graphic outcome assessor(s), and statisticians) will be blinded in this study.
Blinding to participant: will not know either the intervention or the comparative will be applied to their teeth Blinding to outcome assessor: to overcome detection bias Blinding to statisticians: to overcome bias
| WMTA | Drug | White Mineral trioxide aggregates |
|
|